Market Closed -
Toronto S.E.
03:59:59 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.26
CAD
|
-3.70%
|
|
-14.75%
|
-3.70%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
793.6
|
459
|
146.1
|
81.75
|
31.35
|
29.86
|
-
|
Enterprise Value (EV)
1 |
725.1
|
406.9
|
126.6
|
81.75
|
31.35
|
29.86
|
29.86
|
P/E ratio
|
-47.8
x
|
-8.66
x
|
-1.03
x
|
-1.35
x
|
-1.27
x
|
-0.86
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
8.39
x
|
4.82
x
|
1.52
x
|
1.1
x
|
0.5
x
|
0.46
x
|
0.46
x
|
EV / Revenue
|
8.39
x
|
4.82
x
|
1.52
x
|
1.1
x
|
0.5
x
|
0.46
x
|
0.46
x
|
EV / EBITDA
|
-467
x
|
-22.7
x
|
-7.86
x
|
-6.91
x
|
-1.38
x
|
-1.6
x
|
-1.39
x
|
EV / FCF
|
-16.4
x
|
-5.97
x
|
-4.24
x
|
-14.7
x
|
-1.64
x
|
-1.44
x
|
-6.58
x
|
FCF Yield
|
-6.12%
|
-16.7%
|
-23.6%
|
-6.83%
|
-60.9%
|
-69.5%
|
-15.2%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
103,781
|
139,520
|
144,324
|
151,848
|
153,924
|
157,228
|
-
|
Reference price
2 |
7.647
|
3.290
|
1.012
|
0.5384
|
0.2037
|
0.1899
|
0.1899
|
Announcement Date
|
3/24/20
|
3/25/21
|
3/24/22
|
3/23/23
|
3/21/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
94.59
|
95.23
|
96.09
|
74.1
|
63.16
|
64.73
|
65.14
|
EBITDA
1 |
-1.7
|
-20.2
|
-18.6
|
-11.83
|
-22.67
|
-18.71
|
-21.48
|
EBIT
1 |
-24.8
|
-52.47
|
-147.1
|
-18.21
|
-40.61
|
-33.6
|
-
|
Operating Margin
|
-26.22%
|
-55.1%
|
-153.04%
|
-24.57%
|
-64.31%
|
-51.91%
|
-
|
Earnings before Tax (EBT)
1 |
-21.21
|
-40.87
|
-137.6
|
-59.22
|
-23.27
|
-33.6
|
-
|
Net income
1 |
-15.57
|
-47.19
|
-137.7
|
-59.31
|
-23.8
|
-33.6
|
-
|
Net margin
|
-16.46%
|
-49.55%
|
-143.32%
|
-80.04%
|
-37.68%
|
-51.91%
|
-
|
EPS
2 |
-0.1600
|
-0.3800
|
-0.9800
|
-0.4000
|
-0.1600
|
-0.2200
|
-
|
Free Cash Flow
1 |
-48.53
|
-76.85
|
-34.48
|
-5.58
|
-19.08
|
-20.76
|
-4.535
|
FCF margin
|
-51.3%
|
-80.7%
|
-35.88%
|
-7.53%
|
-30.21%
|
-32.06%
|
-6.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/24/20
|
3/25/21
|
3/24/22
|
3/23/23
|
3/21/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
23.7
|
24.83
|
19.36
|
18.88
|
17.04
|
18.9
|
17.01
|
16.01
|
14.29
|
15.84
|
14.3
|
15.7
|
16.8
|
18.8
|
EBITDA
1 |
-2.9
|
-4.5
|
-5.25
|
-5.363
|
0.632
|
-4.503
|
-3.328
|
-7.136
|
-3.549
|
-6.501
|
-4.3
|
-3.6
|
-3.5
|
-2.7
|
EBIT
1 |
-8.985
|
-118.6
|
-8.642
|
-7.938
|
-5.766
|
-6.099
|
-7.596
|
-10.71
|
-11.96
|
-10.35
|
-9.3
|
-8.5
|
-8.3
|
-7.5
|
Operating Margin
|
-37.9%
|
-477.62%
|
-44.65%
|
-42.05%
|
-33.84%
|
-32.27%
|
-44.66%
|
-66.91%
|
-83.67%
|
-65.3%
|
-65.03%
|
-54.14%
|
-49.4%
|
-39.89%
|
Earnings before Tax (EBT)
1 |
-0.913
|
-117.4
|
-8.626
|
-7.87
|
-7.588
|
-35.14
|
-2.912
|
2.844
|
-15.14
|
-8.056
|
-9.3
|
-8.5
|
-8.3
|
-7.5
|
Net income
1 |
-0.913
|
-117.5
|
-8.626
|
-7.87
|
-7.588
|
-35.23
|
-2.912
|
2.844
|
-15.14
|
-8.585
|
-9.3
|
-8.5
|
-8.3
|
-7.5
|
Net margin
|
-3.85%
|
-473.22%
|
-44.56%
|
-41.69%
|
-44.54%
|
-186.4%
|
-17.12%
|
17.77%
|
-105.94%
|
-54.18%
|
-65.03%
|
-54.14%
|
-49.4%
|
-39.89%
|
EPS
2 |
-0.0100
|
-0.8400
|
-0.0600
|
-0.0500
|
-0.0500
|
-0.2300
|
-0.0200
|
0.0200
|
-0.1000
|
-0.0600
|
-0.0600
|
-0.0600
|
-0.0500
|
-0.0500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/15/21
|
3/24/22
|
5/16/22
|
8/9/22
|
11/14/22
|
3/23/23
|
5/12/23
|
8/10/23
|
11/9/23
|
3/21/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
68.5
|
52
|
19.5
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-48.5
|
-76.8
|
-34.5
|
-5.58
|
-19.1
|
-20.8
|
-4.54
|
ROE (net income / shareholders' equity)
|
-10.1%
|
-15.6%
|
-18.4%
|
-76.5%
|
-35.8%
|
-110%
|
-1,067%
|
ROA (Net income/ Total Assets)
|
-6.98%
|
-17.7%
|
-14.7%
|
-31.6%
|
-14%
|
-23.5%
|
-24.3%
|
Assets
1 |
222.9
|
266.9
|
940.1
|
187.6
|
170.1
|
143
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
15.1
|
25.9
|
4.92
|
0.27
|
3.69
|
5
|
0.5
|
Capex / Sales
|
15.91%
|
27.2%
|
5.12%
|
0.36%
|
5.84%
|
7.72%
|
0.77%
|
Announcement Date
|
3/24/20
|
3/25/21
|
3/24/22
|
3/23/23
|
3/21/24
|
-
|
-
|
Last Close Price
0.1899
USD Average target price
0.554
USD Spread / Average Target +191.69% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.70% | 29.86M | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | +0.09% | 1.65B | | -7.89% | 1.68B | | -12.97% | 1.53B | | +33.40% | 1.38B |
Alternative Medicine
|